Showing results (91-100 of 319) with videos related to

Sort By:
Pageof 32
Digestive Diseases and Sciences|May 6, 2014
Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH modelSamjhana Thapaliya, Alexander Wree, Davide Povero, et al.
Experimental Cell Research|March 11, 2008
MARCKS is a downstream effector in platelet-derived growth factor-induced cell motility in activated human hepatic stellate cellsKrista Rombouts, Benedetta Lottini, Alessandra Caligiuri, et al.
Hepatology (Baltimore, Md.)|January 11, 2017
The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cellsFrancesca Virginia Bruschi, Thierry Claudel, Matteo Tardelli, et al.
The Korean Journal of Internal Medicine|April 4, 2020
Alcohol use disorder and liver transplant: new perspectives and critical issuesStefano Gitto, Silvia Aspite, Lucia Golfieri, et al.
BJR Case Reports|February 19, 2024
Management of a complex transjugular intrahepatic portosystemic shunt dysfunction with endotipsitis through rotational thrombectomyFrancesco Vizzutti, Emanuele Casamassima, Gianmarco Falcone, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2023
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from a German real-world cohortFabian Jost-Brinkmann, Münevver Demir, Alexander Wree, et al.
European Journal of Clinical Investigation|March 14, 2013
Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromesMaria Boddi, Roberto Tarquini, Marco Chiostri, et al.
Annals of Hepatology|September 1, 2019
Impact of psychosocial status on liver transplant processLucia Golfieri, Stefano Gitto, Ranka Vukotic, et al.
Pageof 32